Clinical Trial Update: Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial update on fractionated busulfan conditioning before allogeneic stem cell transplantation in myeloid malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Malignancies

Drugs mentioned

• busulfan (fractionated conditioning regimen) (busulfan)

Snippet

Sponsor: Sichuan University | Conditions: Myeloid Malignancies | Phase 2 | Status: UNKNOWN